http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09507242-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3211 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-32 |
| filingDate | 1994-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1997-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H09507242-A |
| titleOfInvention | Hydrazides of phosphorylated carboxylic acids with therapeutic activity |
| abstract | (57) [Summary] General formula (I): (Wherein each X is independently halogeno, hydroxy, C 1-4 alkyl, C 1-4 alkoxy, nitro or an unsubstituted or substituted amino group NRR ′, wherein R and R ′ are each independently hydrogen, C 1-4 alkyl group and C 2-4 halogenated alkyl group; Y is halogeno, hydroxy, C 1-4 alkoxy or an unsubstituted or substituted amino group NRR ′, wherein R and R ′ are as defined above. N is 0, 1, 2 or 3, n'is 1, 2, 3 or 4; R 1 and R 2 are each independently hydrogen, halogeno, phenyl, a C 1-4 alkyl group. Or is taken together to represent the group = NOR ", where R" is hydrogen or is the group ZC (O)-or (ZO) 2 P (O)-, where Z is C 1 There -4 alkyl group; and R 3 and R 4 it Separately hydrogen, acetyl, phenyl, or 2,2,2-trichloro-1-hydroxyethyl or C 1-4 alkyl group, or together The nyl group is 1-3 selected from halogeno, hydroxy, C 1-4 alkyl, C 1-4 alkoxy, nitro and unsubstituted or substituted amino groups NRR ′, where R and R ′ are as defined above. Compounds optionally substituted with individual groups); optionally in the form of physiologically acceptable salts, the compounds are useful for the treatment of depression and / or memory enhancement. |
| priorityDate | 1994-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.